TrialClinical pharmacokinetics2011

Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.

Wolfgang Mueck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.